Therapeutic Options in IgG4-Related Disease

被引：0
作者：
Andreu Fernández-Codina
Olimpia Orozco-Gálvez
Fernando Martínez-Valle
机构：
[1] Hospital Universitari Vall d’Hebron,General Internal Medicine department, Systemic Autoimmune Diseases unit
[2] University of Western Ontario,Rheumatology division
[3] University of Western Ontario,General Internal Medicine department
来源：
Current Treatment Options in Rheumatology | 2020年 / 6卷
关键词：
IgG4-related disease; Treatment; Autoimmunity; DMARDs; Rituximab; Glucocorticoids;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：191 / 204
页数：13
相关论文
共 471 条
  • [1] Uchida K(2012)Prevalence of IgG4-related disease in Japan based on Nationwide survey in 2009 Int J Rheumatol. 2012 1-5
  • [2] Masamune A(2003)A new clinicopathological entity of IgG4-related autoimmune disease J Gastroenterol 38 982-984
  • [3] Shimosegawa T(2012)Consensus statement on the pathology of IgG4-related disease Mod Pathol 25 1181-1192
  • [4] Okazaki K(2018)Laminin 511 is a target antigen in autoimmune pancreatitis Sci Transl Med 10 1-11
  • [5] Kamisawa T(2014)De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease J Allergy Clin Immunol Elsevier Ltd 134 679-687
  • [6] Funata N(2017)Clonally expanded cytotoxic CD4 Autoimmunity. 50 19-24
  • [7] Hayashi Y(2015) T cells and the pathogenesis of IgG4-related disease Clin Exp Immunol 181 191-206
  • [8] Eishi Y(2014)Immunology of IgG4-related disease Ann Rheum Dis 74 14-18
  • [9] Koike M(2017)The diagnostic utility of serum IgG4 concentrations in IgG4-related disease Autoimmun Rev 16 168-172
  • [10] Tsuruta K(2012)IgG4-related disease: evidence from six recent cohorts Mod Rheumatol 22 21-30
12345678910